Ignite Creation Date:
2025-12-24 @ 2:00 PM
Ignite Modification Date:
2026-01-26 @ 11:56 AM
Study NCT ID:
NCT05937295
Status:
RECRUITING
Last Update Posted:
2024-12-09
First Post:
2023-05-09
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
FusionVAC22_01: Fusion Transcript-based Peptide Vaccine Combined with Immune Checkpoint Inhibition
Sponsor:
University Hospital Tuebingen
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
FusionVAC22_01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None